The prognostic value of B7-H6 in esophageal squamous cell carcinoma
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The prognostic value of B7-H6 in esophageal squamous cell carcinoma
Authors
Keywords
-
Journal
Scientific Reports
Volume 9, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-12-02
DOI
10.1038/s41598-019-54731-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- B7-H6 expression is induced by lipopolysaccharide and facilitates cancer invasion and metastasis in human gliomas
- (2018) Fengyuan Che et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Safety and Antitumor Activity of the Anti–Programmed Death-1 Antibody Pembrolizumab in Patients With Advanced Esophageal Carcinoma
- (2018) Toshihiko Doi et al. JOURNAL OF CLINICAL ONCOLOGY
- Expression of B7-H6 expression in human hepatocellular carcinoma and its clinical significance
- (2018) Lujun Chen et al. Cancer Cell International
- Nivolumab treatment for oesophageal squamous-cell carcinoma: an open-label, multicentre, phase 2 trial
- (2017) Toshihiro Kudo et al. LANCET ONCOLOGY
- New B7 Family Checkpoints in Human Cancers
- (2017) Ling Ni et al. MOLECULAR CANCER THERAPEUTICS
- The B7 Family Member B7-H6: a New Bane of Tumor
- (2017) Ying Chen et al. PATHOLOGY & ONCOLOGY RESEARCH
- Immunotherapy for Esophageal Squamous Cell Carcinoma
- (2017) Takashi Kojima et al. Current Oncology Reports
- Clinical significance of novel costimulatory molecule B7-H6 in human breast cancer
- (2017) Jing Sun et al. Oncology Letters
- High expression of B7-H6 in human glioma tissues promotes tumor progression
- (2017) Tianwei Jiang et al. Oncotarget
- Advances in immunotherapy for melanoma
- (2016) Jason M. Redman et al. BMC Medicine
- Changes in tumour expression of programmed death-ligand 1 after neoadjuvant concurrent chemoradiotherapy in patients with squamous oesophageal cancer
- (2016) S.H. Lim et al. EUROPEAN JOURNAL OF CANCER
- Knockdown of B7-H6 inhibits tumor progression and enhances chemosensitivity in B-cell non-Hodgkin lymphoma
- (2016) FEIFEI WU et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Checkpoint inhibitors and other novel immunotherapies for advanced renal cell carcinoma
- (2016) Maria I. Carlo et al. Nature Reviews Urology
- Epidermal growth factor receptor and B7-H3 expression in esophageal squamous tissues correlate to patient prognosis
- (2016) Jianxiang Song et al. OncoTargets and Therapy
- Clinical significance of B7-H6 protein expression in astrocytoma
- (2016) Jian-gui Guo et al. OncoTargets and Therapy
- Relationship between expression of PD-L1 and PD-L2 on esophageal squamous cell carcinoma and the antitumor effects of CD8+ T cells
- (2015) CHANGSEN LENG et al. ONCOLOGY REPORTS
- Roles of coinhibitory molecules B7-H3 and B7-H4 in esophageal squamous cell carcinoma
- (2015) Ling Wang et al. TUMOR BIOLOGY
- Metalloprotease-Mediated Tumor Cell Shedding of B7-H6, the Ligand of the Natural Killer Cell-Activating Receptor NKp30
- (2014) E. Schlecker et al. CANCER RESEARCH
- Induction of B7-H6, a ligand for the natural killer cell-activating receptor NKp30, in inflammatory conditions
- (2013) J. Matta et al. BLOOD
- Oesophageal carcinoma
- (2013) Arjun Pennathur et al. LANCET
- B7-H6 Protein Expression has no Prognostic Significance in Human Gastric Carcinoma
- (2013) Xiao-Juan Chen et al. PATHOLOGY & ONCOLOGY RESEARCH
- The expression, function, and clinical relevance of B7 family members in cancer
- (2012) Barbara Seliger et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- B7-H4 expression associates with cancer progression and predicts patient’s survival in human esophageal squamous cell carcinoma
- (2011) Lu-jun Chen et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- B7-H6/NKp30 interaction: a mechanism of alerting NK cells against tumors
- (2011) Tomonori Kaifu et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- T-cell-mediated tumor immune surveillance and expression of B7 co-inhibitory molecules in cancers of the upper gastrointestinal tract
- (2011) Binfeng Lu et al. IMMUNOLOGIC RESEARCH
- VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responses
- (2011) Li Wang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Crystal structure of human natural cytotoxicity receptor NKp30 and identification of its ligand binding site
- (2011) M. G. Joyce et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
- (2011) R. D. Schreiber et al. SCIENCE
- The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans
- (2009) Cameron S. Brandt et al. JOURNAL OF EXPERIMENTAL MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started